NewsMarkets

Business

AstraZeneca Opens $1 Billion R&D Center in Kendall Square, Massachusetts

The new facility will house nearly 2,000 researchers and expand the company's local workforce by over 50 percent.

2 publishers · 3 articles · first seen 5 Oct 2026 · updated 1h ago

The story so far

2 publishers have covered this in 3 articles since 5 Oct 2026. Quartz published first, on 5 October at 17:52 UTC; CNBC followed 1h 52m later. The most recent article, from CNBC, appeared on 5 October at 19:44 UTC.

Outlets reporting it: CNBC (major outlet), Quartz.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment CNBC ·
  2. AstraZeneca eröffnet ein 1 Milliarde Dollar teures F&E-Zentrum in Kendall Square. Quartz
  3. AstraZeneca opens $1 billion R&D center in Kendall Square Quartz

In this story

  • AstraZeneca
  • Pascal Soriot
  • Kendall Square
  • Massachusetts
Embed this story

Paste this into any web page to show the live odds, with a link back here.